Skip to Main Content
Try STAT+ TODAY
Trending:
Biotech
Health
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Chinese ingredients maker plays hide and seek with FDA inspectors

  • Ed Silverman

By Ed Silverman Nov. 2, 2016

Reprints
FDA Securities Fraud
US FDA sent a warning letter to a Chinese pharma ingredient manufacturer for blocking inspections Andrew Harnik/AP

Drums? What drums?

Yet another foreign company tried to fool the US Food and Drug Administration, but without success.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Tracking the bird flu, experts see a familiar threat…
Tracking the bird flu, experts see a familiar threat — and a virus whose course is…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina,…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
Mindstrong’s demise and the future of mental health care
Mindstrong’s demise and the future of mental health care
Pharma loses a court battle in its bid to…
Pharma loses a court battle in its bid to block states from importing drugs from Canada
Pharmalittle: Biden to call for expanding caps on insulin…
Pharmalittle: Biden to call for expanding caps on insulin prices; families seek to override Vertex CF…
Angry at Vertex pricing of cystic fibrosis drugs, families…
Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents

Recommended Stories